Do analysts recommend BBLG or NXL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bone Biologics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Nexalin Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer BBLG or NXL?

In the previous week, Nexalin Technology had 3 more articles in the media than Bone Biologics. MarketBeat recorded 6 mentions for Nexalin Technology and 3 mentions for Bone Biologics. Bone Biologics' average media sentiment score of 0.57 beat Nexalin Technology's score of 0.31 indicating that Bone Biologics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bone Biologics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nexalin Technology 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate BBLG or AMIX?

Autonomix Medical has a consensus price target of $42.00, suggesting a potential upside of 689.47%. Given Autonomix Medical's stronger consensus rating and higher probable upside, analysts clearly believe Autonomix Medical is more favorable than Bone Biologics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bone Biologics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Autonomix Medical 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation and earnings, BBLG or AMIX?

Bone Biologics is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bone Biologics N/A N/A -$3.11M -$1.37 N/A Autonomix Medical N/A N/A -$16.72M -$41.57 N/A

Is BBLG or AMIX more profitable?

Bone Biologics' return on equity of -57.87% beat Autonomix Medical's return on equity. Company Net Margins Return on Equity Return on Assets Bone Biologics N/A -57.87% -53.65% Autonomix Medical N/A -267.73% -216.75%

Does the media prefer BBLG or AMIX?

In the previous week, Autonomix Medical had 5 more articles in the media than Bone Biologics. MarketBeat recorded 8 mentions for Autonomix Medical and 3 mentions for Bone Biologics. Autonomix Medical's average media sentiment score of 0.90 beat Bone Biologics' score of 0.57 indicating that Autonomix Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bone Biologics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Autonomix Medical 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate SONX or BBLG?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Bone Biologics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is SONX or BBLG more profitable?

Bone Biologics has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Bone Biologics' return on equity of -57.87% beat Sonendo's return on equity. Company Net Margins Return on Equity Return on Assets Sonendo -92.74% -184.01% -68.60% Bone Biologics N/A -57.87% -53.65%

Does the media favor SONX or BBLG?

In the previous week, Bone Biologics had 2 more articles in the media than Sonendo. MarketBeat recorded 3 mentions for Bone Biologics and 1 mentions for Sonendo. Bone Biologics' average media sentiment score of 0.57 beat Sonendo's score of 0.00 indicating that Bone Biologics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sonendo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bone Biologics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer BBLG or XAIR?

Beyond Air has a consensus target price of $200.00, indicating a potential upside of 4,364.29%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts plainly believe Beyond Air is more favorable than Bone Biologics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bone Biologics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Beyond Air 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Is BBLG or XAIR more profitable?

Bone Biologics has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. Bone Biologics' return on equity of -57.87% beat Beyond Air's return on equity. Company Net Margins Return on Equity Return on Assets Bone Biologics N/A -57.87% -53.65% Beyond Air -435.71% -440.26% -98.50%

Does the media refer more to BBLG or XAIR?

In the previous week, Bone Biologics and Bone Biologics both had 3 articles in the media. Beyond Air's average media sentiment score of 0.62 beat Bone Biologics' score of 0.57 indicating that Beyond Air is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bone Biologics 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Beyond Air 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer VSA or BBLG?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TCTM Kids IT Education 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Bone Biologics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is VSA or BBLG more profitable?

TCTM Kids IT Education's return on equity of 0.00% beat Bone Biologics' return on equity. Company Net Margins Return on Equity Return on Assets TCTM Kids IT Education N/A N/A N/A Bone Biologics N/A -57.87% -53.65%

Bone Biologics (BBLG) Competitors

$0.62 0.00 (0.00%)

Closing price 08/28/2026 04:00 PM Eastern

Extended Trading

$0.59 -0.03 (-4.23%)

As of 05:00 AM Eastern

Compare

BBLG vs. NXL, AMIX, SONX, XAIR, and VSA

Should you buy Bone Biologics stock or one of its competitors? Bone Biologics's main competitors and comparable companies include Nexalin Technology (NXL), Autonomix Medical (AMIX), Sonendo (SONX), Beyond Air (XAIR), and TCTM Kids IT Education (VSA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Bone Biologics compare to Nexalin Technology?

Bone Biologics (NASDAQ:BBLG) and Nexalin Technology (NASDAQ:NXL) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

Bone Biologics has higher earnings, but lower revenue than Nexalin Technology. Nexalin Technology is trading at a lower price-to-earnings ratio than Bone Biologics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bone Biologics	N/A	N/A	-$3.11M	-$1.37	N/A
Nexalin Technology	$217.16K	25.86	-$8.22M	-$0.48	N/A

34.3% of Bone Biologics shares are held by institutional investors. Comparatively, 0.6% of Nexalin Technology shares are held by institutional investors. 5.6% of Bone Biologics shares are held by insiders. Comparatively, 16.9% of Nexalin Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Bone Biologics has a net margin of 0.00% compared to Nexalin Technology's net margin of -4,141.94%. Bone Biologics' return on equity of -57.87% beat Nexalin Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bone Biologics	N/A	-57.87%	-53.65%
Nexalin Technology	-4,141.94%	-278.24%	-218.42%

Bone Biologics has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market. Comparatively, Nexalin Technology has a beta of 4, indicating that its share price is 300% more volatile than the broader market.

In the previous week, Nexalin Technology had 3 more articles in the media than Bone Biologics. MarketBeat recorded 6 mentions for Nexalin Technology and 3 mentions for Bone Biologics. Bone Biologics' average media sentiment score of 0.57 beat Nexalin Technology's score of 0.31 indicating that Bone Biologics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bone Biologics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nexalin Technology	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bone Biologics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Nexalin Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Bone Biologics beats Nexalin Technology on 7 of the 12 factors compared between the two stocks.

How does Bone Biologics compare to Autonomix Medical?

Bone Biologics (NASDAQ:BBLG) and Autonomix Medical (NASDAQ:AMIX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, analyst recommendations, institutional ownership, profitability, valuation and risk.

Bone Biologics' return on equity of -57.87% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bone Biologics	N/A	-57.87%	-53.65%
Autonomix Medical	N/A	-267.73%	-216.75%

Bone Biologics is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bone Biologics	N/A	N/A	-$3.11M	-$1.37	N/A
Autonomix Medical	N/A	N/A	-$16.72M	-$41.57	N/A

Bone Biologics has a beta of 0.93, suggesting that its stock price is 7% less volatile than the broader market. Comparatively, Autonomix Medical has a beta of -1.16, suggesting that its stock price is 216% less volatile than the broader market.

34.3% of Bone Biologics shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 5.6% of Bone Biologics shares are held by company insiders. Comparatively, 6.2% of Autonomix Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Autonomix Medical has a consensus price target of $42.00, suggesting a potential upside of 689.47%. Given Autonomix Medical's stronger consensus rating and higher probable upside, analysts clearly believe Autonomix Medical is more favorable than Bone Biologics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bone Biologics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Autonomix Medical had 5 more articles in the media than Bone Biologics. MarketBeat recorded 8 mentions for Autonomix Medical and 3 mentions for Bone Biologics. Autonomix Medical's average media sentiment score of 0.90 beat Bone Biologics' score of 0.57 indicating that Autonomix Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bone Biologics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Autonomix Medical	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Autonomix Medical beats Bone Biologics on 7 of the 13 factors compared between the two stocks.

How does Bone Biologics compare to Sonendo?

Sonendo (NYSE:SONX) and Bone Biologics (NASDAQ:BBLG) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

Bone Biologics has lower revenue, but higher earnings than Sonendo. Bone Biologics is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.11	-$60.92M	-$71.12	N/A
Bone Biologics	N/A	N/A	-$3.11M	-$1.37	N/A

Sonendo has a beta of 1.81, suggesting that its share price is 81% more volatile than the broader market. Comparatively, Bone Biologics has a beta of 0.93, suggesting that its share price is 7% less volatile than the broader market.

In the previous week, Bone Biologics had 2 more articles in the media than Sonendo. MarketBeat recorded 3 mentions for Bone Biologics and 1 mentions for Sonendo. Bone Biologics' average media sentiment score of 0.57 beat Sonendo's score of 0.00 indicating that Bone Biologics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sonendo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Bone Biologics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Bone Biologics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Bone Biologics has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Bone Biologics' return on equity of -57.87% beat Sonendo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Bone Biologics	N/A	-57.87%	-53.65%

28.7% of Sonendo shares are owned by institutional investors. Comparatively, 34.3% of Bone Biologics shares are owned by institutional investors. 7.9% of Sonendo shares are owned by company insiders. Comparatively, 5.6% of Bone Biologics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Bone Biologics beats Sonendo on 9 of the 13 factors compared between the two stocks.

How does Bone Biologics compare to Beyond Air?

Bone Biologics (NASDAQ:BBLG) and Beyond Air (NASDAQ:XAIR) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, valuation, earnings, institutional ownership and dividends.

Bone Biologics has higher earnings, but lower revenue than Beyond Air. Bone Biologics is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bone Biologics	N/A	N/A	-$3.11M	-$1.37	N/A
Beyond Air	$7.68M	0.56	-$33.25M	-$68.40	N/A

Beyond Air has a consensus target price of $200.00, indicating a potential upside of 4,364.29%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts plainly believe Beyond Air is more favorable than Bone Biologics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bone Biologics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Beyond Air	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Bone Biologics has a beta of 0.93, suggesting that its share price is 7% less volatile than the broader market. Comparatively, Beyond Air has a beta of 0.23, suggesting that its share price is 77% less volatile than the broader market.

In the previous week, Bone Biologics and Bone Biologics both had 3 articles in the media. Beyond Air's average media sentiment score of 0.62 beat Bone Biologics' score of 0.57 indicating that Beyond Air is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bone Biologics	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Beyond Air	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

34.3% of Bone Biologics shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 5.6% of Bone Biologics shares are owned by insiders. Comparatively, 10.0% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Bone Biologics has a net margin of 0.00% compared to Beyond Air's net margin of -435.71%. Bone Biologics' return on equity of -57.87% beat Beyond Air's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bone Biologics	N/A	-57.87%	-53.65%
Beyond Air	-435.71%	-440.26%	-98.50%

Summary

Bone Biologics and Beyond Air tied by winning 7 of the 14 factors compared between the two stocks.

How does Bone Biologics compare to TCTM Kids IT Education?

TCTM Kids IT Education (NASDAQ:VSA) and Bone Biologics (NASDAQ:BBLG) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

TCTM Kids IT Education has higher revenue and earnings than Bone Biologics. Bone Biologics is trading at a lower price-to-earnings ratio than TCTM Kids IT Education, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TCTM Kids IT Education	$1.04M	4.02	$245.80M	$45.00	0.08
Bone Biologics	N/A	N/A	-$3.11M	-$1.37	N/A

TCTM Kids IT Education's return on equity of 0.00% beat Bone Biologics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TCTM Kids IT Education	N/A	N/A	N/A
Bone Biologics	N/A	-57.87%	-53.65%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TCTM Kids IT Education	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Bone Biologics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

49.8% of TCTM Kids IT Education shares are held by institutional investors. Comparatively, 34.3% of Bone Biologics shares are held by institutional investors. 32.9% of TCTM Kids IT Education shares are held by company insiders. Comparatively, 5.6% of Bone Biologics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

TCTM Kids IT Education has a beta of 0.51, indicating that its share price is 49% less volatile than the broader market. Comparatively, Bone Biologics has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market.

In the previous week, Bone Biologics had 2 more articles in the media than TCTM Kids IT Education. MarketBeat recorded 3 mentions for Bone Biologics and 1 mentions for TCTM Kids IT Education. TCTM Kids IT Education's average media sentiment score of 1.89 beat Bone Biologics' score of 0.57 indicating that TCTM Kids IT Education is being referred to more favorably in the media.

Company	Overall Sentiment
TCTM Kids IT Education	Very Positive
Bone Biologics	Positive

Summary

TCTM Kids IT Education beats Bone Biologics on 9 of the 11 factors compared between the two stocks.

Get Bone Biologics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BBLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BBLG vs. The Competition

Export

Metric	Bone Biologics	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.70M	$5.78B	$7.18B	$12.88B
Dividend Yield	N/A	1.75%	2.54%	11.27%
P/E Ratio	-0.45	25.92	273.17	25.45
Price / Sales	N/A	78.92	638.13	103.78
Price / Cash	N/A	33.69	28.74	36.03
Price / Book	0.21	6.18	11.08	6.36
Net Income	-$3.11M	$149.94M	$3.48B	$349.79M
7 Day Performance	1.22%	-0.70%	0.21%	-0.48%
1 Month Performance	-27.65%	5.99%	7.75%	4.17%
1 Year Performance	-71.40%	6.19%	24.68%	15.11%

Bone Biologics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BBLG Bone Biologics	0.723 of 5 stars	$0.62 flat	N/A	-71.4%	$1.70M	N/A	N/A	2	Gap Down
NXL Nexalin Technology	0.4209 of 5 stars	$0.25 -13.6%	N/A	-73.9%	$6.63M	$217.16K	N/A	3	Upcoming Earnings Gap Down High Trading Volume
AMIX Autonomix Medical	3.3031 of 5 stars	$5.63 -11.8%	$42.00 +646.0%	-77.4%	$6.20M	N/A	N/A	1	Analyst Downgrade Short Interest Decrease Gap Down
SONX Sonendo	N/A	$1.00 flat	N/A	N/A	$4.78M	$44.40M	N/A	250	Gap Up
XAIR Beyond Air	3.3585 of 5 stars	$5.70 +14.7%	$200.00 +3,408.8%	-89.9%	$4.76M	$7.68M	N/A	70	Gap Down High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BBLG) was last updated on 8/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bone Biologics (BBLG) Competitors

BBLG vs. NXL, AMIX, SONX, XAIR, and VSA

How does Bone Biologics compare to Nexalin Technology?

Summary

How does Bone Biologics compare to Autonomix Medical?

Summary

How does Bone Biologics compare to Sonendo?

Summary

How does Bone Biologics compare to Beyond Air?

Summary

How does Bone Biologics compare to TCTM Kids IT Education?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BBLG vs. The Competition

Bone Biologics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bone Biologics (BBLG) Competitors

BBLG vs. NXL, AMIX, SONX, XAIR, and VSA

How does Bone Biologics compare to Nexalin Technology?

Which has higher earnings and valuation, BBLG or NXL?

Do insiders & institutionals have more ownership in BBLG or NXL?

Is BBLG or NXL more profitable?

Which has more risk and volatility, BBLG or NXL?

Does the media prefer BBLG or NXL?

Do analysts recommend BBLG or NXL?

Summary

How does Bone Biologics compare to Autonomix Medical?

Is BBLG or AMIX more profitable?

Which has higher valuation and earnings, BBLG or AMIX?

Which has more risk and volatility, BBLG or AMIX?

Do insiders and institutionals hold more shares of BBLG or AMIX?

Do analysts rate BBLG or AMIX?

Does the media prefer BBLG or AMIX?

Summary

How does Bone Biologics compare to Sonendo?

Which has stronger valuation & earnings, SONX or BBLG?

Which has more volatility & risk, SONX or BBLG?

Does the media favor SONX or BBLG?

Do analysts rate SONX or BBLG?

Is SONX or BBLG more profitable?

Do insiders and institutionals hold more shares of SONX or BBLG?

Summary

How does Bone Biologics compare to Beyond Air?

Which has preferable valuation and earnings, BBLG or XAIR?

Do analysts prefer BBLG or XAIR?

Which has more volatility & risk, BBLG or XAIR?

Does the media refer more to BBLG or XAIR?

Do insiders & institutionals have more ownership in BBLG or XAIR?

Is BBLG or XAIR more profitable?

Summary

How does Bone Biologics compare to TCTM Kids IT Education?

Which has preferable earnings and valuation, VSA or BBLG?

Is VSA or BBLG more profitable?

Do analysts prefer VSA or BBLG?

Do institutionals & insiders hold more shares of VSA or BBLG?

Which has more volatility and risk, VSA or BBLG?

Does the media favor VSA or BBLG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BBLG vs. The Competition

Bone Biologics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools